Delivery Order SPE2DB20D2104-SPE2DB22FS86Y
Award Date 5/27/22
Potential Completion Date 5/31/22
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Bromfenac Sodium 0.09% eye drops, valued at $3,445.49, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% Eye Drops (1.7 mL) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $6,447.52, has an ultimate completion date of October 16, 2024. This award is not designated as a set-aside contract. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromfenac Sodium 0.09% eye drops. The $2,180.46 Firm Fixed Price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by Amerisourcebergen's parent company, Cencora, Inc., which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- The federal contract award detailed is for the delivery of Bromfenac Sodium 0.09% Eye Drops 1.7mL, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,046.48 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 26, 2023. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, is for the delivery of Bromfenac Sodium 0.09% Eye Drops 1.7ML. The $1,575.92 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 5, 2024. The contract is not designated as a set-aside award. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,388.91, is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract is a Delivery Order, with a Firm Fixed Price pricing type and an ultimate completion date of October 26, 2023. The contract was awarded on October 25, 2023 and does not have a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Bromfenac Sodium 0.09% Eye Drops in 1.7 ML bottles, with a total ceiling value of $8,869.82. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.68 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a performance period ending on May 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.74, is for the supply of Bromfenac Sodium 0.09% Eye Drops in 1.7 ml containers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...